mrna-20201231
COVID-19 mRNA vaccines: Platforms and current developments - ScienceDirect
The co-founder of BioNTech designed the coronavirus vaccine it made with Pfizer in just a few hours over a single day | Business Insider India
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery: Molecular Therapy
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency | Signal Transduction and Targeted Therapy
Pfizer-BioNTech COVID-19 vaccine may not be associated with adverse effects on fertility and breastfeeding, says study
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2 - ScienceDirect
How Moderna's Vaccine Works - FV Hospital
RACGP - Four things about mRNA vaccines researchers still want to find out
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
CIMB | Free Full-Text | Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
MRNA Covid Vaccine Access Carves Up World Into Haves and Have-Nots - Bloomberg
This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines | Science | AAAS
MÉDECINS DU MONDE INTERNATIONAL NETWORK CHALLENGES PFIZER/BIONTECH MONOPOLY ON THE COVID-19 VACCINE | Dünya Doktorları
RACGP - Four things about mRNA vaccines researchers still want to find out
How mRNA Vaccines Might Help Treat Cancer - NCI
mRNA vaccine for cancer immunotherapy | Molecular Cancer | Full Text
RNA Vaccines (mRNA Vaccine) - Basis of Pfizer and Moderna COVID-19 vaccines, Animation - YouTube
COVID-19 mRNA vaccines: How could anything developed this quickly be safe? - News | UAB
mRNA vaccines against COVID-19: Pfizer-BioNTech COVID-19 vaccine BNT162b2: prepared by the Strategic Advisory Group of Experts (SAGE) on immunization working group on COVID-19 vaccines, 22 December 2020
Frontiers | Perspectives on RNA Vaccine Candidates for COVID-19
Szegedi Tudományegyetem | Katalin Karikó, an Alumna of the University of Szeged, is the Founder of the Most Promising Vaccine Development against the Coronavirus
IJMS | Free Full-Text | mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
